Prostate cancer is the second leading cause of cancer deaths and the seventh overall cause
of death in men in the United States (Centers for Disease Control and Prevention, 2008).
Given that most new cases are diagnosed at an early, localized stage, significant attention
has been focused on understanding the risks and benefits of alternative management
strategies for patients with low-risk disease. The major options include active surveillance
and various forms of radiation therapy and surgery. Data to compare the long-term
survival benefits of these options are limited, and thus the choice for many patients is based
largely on considerations of the potential short and long-term side effects of different
Interventions of Interest:
- Brachytherapy and Proton beam therapy for prostate cancer.
Date of Review: December 2008
For questions or additional information, please contact firstname.lastname@example.org
Below you will find the final documents from the assessment review process: